Vivos Therapeutics (VVOS) Stock: Buy, Sell, or Hold?
VVOS - Vivos Therapeutics, Inc. Common Stock
$0.13
0.00 (0.91%)
▲
5d:
+1.98%
30d:
-8.11%
90d:
-66.82%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 18, 2026
24d
Get Alerted When VVOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VVOS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VVOS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: VVOS is currently trading at $0.13, which is considered oversold relative to its 30-day fair value range of $0.14 to $0.16.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.15.
Market Sentiment: VVOS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.12 (+1483.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.12, while resistance sits at $0.15.
Market Sentiment: VVOS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.12 (+1483.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.14 -
$0.16
Company Quality Score
40/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (31/100)
- BULLISH: Trading 1483.2% below Wall St target ($2.12)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.14 -
$0.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.12
Resistance Level
$0.15
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.16
Wall Street Target
$2.12
(+1483.2%)
Revenue Growth (YoY)
34.9%
Profit Margin
-121.8%
Share & Embed Analysis
Last updated: October 24, 2026 7:20 AM ET
Data refreshes hourly during market hours. Next update: 8:20 AM
Data refreshes hourly during market hours. Next update: 8:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VVOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 52 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
